{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:31:13Z","timestamp":1762176673639},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,15]]},"DOI":"10.1093\/cid\/cit329","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T23:20:11Z","timestamp":1374708011000},"page":"S46-S50","source":"Crossref","is-referenced-by-count":28,"title":["Hepatitis C Virus Vaccines Among People Who Inject Drugs"],"prefix":"10.1093","volume":"57","author":[{"given":"Andrea L.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,8,15]]},"reference":[{"key":"key\n\t\t\t\t20171013234149_CIT329C1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C virus infections among injection drug users in Baltimore","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine"},{"key":"key\n\t\t\t\t20171013234149_CIT329C2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013234149_CIT329C3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/162.4.823","article-title":"Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam","volume":"162","author":"van den Hoek","year":"1990","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5694\/j.1326-5377.1990.tb136899.x","article-title":"Epidemiology and hepatitis C virus in Victoria","volume":"153","author":"Fairley","year":"1990","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20171013234149_CIT329C5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4269\/ajtmh.2006.74.1111","article-title":"Hepatitis C infection among drug users in northern Thailand","volume":"74","author":"Jittiwutikarn","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20171013234149_CIT329C6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1086\/649783","article-title":"Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities","volume":"201","author":"Hagan","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1753-6405.2007.00007.x","article-title":"High hepatitis C incidence in new injecting drug users: a policy failure?","volume":"31","author":"Maher","year":"2007","journal-title":"Aust N Z J Public Health"},{"issue":"suppl 1","key":"key\n\t\t\t\t20171013234149_CIT329C8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/00042560-199802001-00004","article-title":"Prevalence and incidence of hepatitis C virus infection among young adult injection drug users","volume":"18","author":"Garfein","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/infdis\/jiq112","article-title":"Changes in blood-borne infection risk among injection drug users","volume":"203","author":"Mehta","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C11","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013234149_CIT329C12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/656212","article-title":"Survival of hepatitis C virus in syringes: implication for transmission among injection drug users","volume":"202","author":"Paintsil","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C13","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/infdis\/jir650","article-title":"Hepatitis C transmission in injection drug users: could swabs be the main culprit?","volume":"204","author":"Thibault","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/infdis\/jis677","article-title":"Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment","volume":"207","author":"Doerrbecker","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.315.7104.333","article-title":"Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus","volume":"315","author":"Dore","year":"1997","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171013234149_CIT329C16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20171013234149_CIT329C17","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171013234149_CIT329C18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nm1353","article-title":"A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees","volume":"12","author":"Folgori","year":"2006","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171013234149_CIT329C19","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C20","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1053\/jhep.2001.24371","article-title":"Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection","volume":"33","author":"Bassett","year":"2001","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C21","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1086\/496889","article-title":"Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model","volume":"192","author":"Prince","year":"2005","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.21376","article-title":"Hepatitis C virus reinfection in injection drug users","volume":"44","author":"Grebely","year":"2006","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2009.07.002","article-title":"HCV reinfection studies and the door to vaccine development","volume":"51","author":"Grebely","year":"2009","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jis213","article-title":"The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design","volume":"205","author":"Vickerman","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013234149_CIT329C28","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171013234149_CIT329C29","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171013234149_CIT329C30","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C32","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1073\/pnas.91.4.1294","article-title":"Vaccination of chimpanzees against infection by the hepatitis C virus","volume":"91","author":"Choo","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171013234149_CIT329C34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2003.09.010","article-title":"Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection","volume":"22","author":"Puig","year":"2004","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20171013234149_CIT329C35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1053\/jhep.2000.9877","article-title":"Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV","volume":"32","author":"Forns","year":"2000","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171013234149_CIT329C36","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171013234149_CIT329C37","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1128\/JVI.77.8.4781-4793.2003","article-title":"Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees","volume":"77","author":"Nascimbeni","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20171013234149_CIT329C39","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1128\/JVI.01179-08","article-title":"Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus","volume":"82","author":"Youn","year":"2008","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C40","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.0702162104","article-title":"Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees","volume":"104","author":"Elmowalid","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171013234149_CIT329C41","doi-asserted-by":"crossref","first-page":"115ra1","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20171013234149_CIT329C42","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013234149_CIT329C43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171013234149_CIT329C44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis","volume":"52","author":"Cardoso","year":"2010","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171013234149_CIT329C45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/57\/suppl_2\/S46\/20912699\/cit329.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T16:46:35Z","timestamp":1596213995000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/57\/suppl_2\/S46\/399830\/Hepatitis-C-Virus-Vaccines-Among-People-Who-Inject"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,15]]},"references-count":45,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2013,8,15]]},"published-print":{"date-parts":[[2013,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit329","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,8,15]]},"published":{"date-parts":[[2013,8,15]]}}}